seminars:datasci:112823
Differences
This shows you the differences between two versions of the page.
| seminars:datasci:112823 [2023/11/07 20:11] – created gfu | seminars:datasci:112823 [2023/11/07 20:13] (current) – gfu | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| + | <WRAP centeralign>## | ||
| + | |||
| + | * Date: Tuesday, November 28, 2023 | ||
| + | * Time: 12:00-1:00 EST | ||
| + | * Room: zoom | ||
| + | * Speaker: Dr. Li Zhang (University of California San Francisco) | ||
| + | * Title: NAIR Software: Unlocking the Immune System' | ||
| + | |||
| + | <WRAP center box 80%> | ||
| + | <WRAP centeralign> | ||
| + | \\ | ||
| + | Immunotherapy has revolutionized cancer treatment, which depends on the immune system to | ||
| + | mediate responses. Significant advances have been made through high-dimension sequences to | ||
| + | dissect the immune responses in patients. T cells play a vital role in our body's immune defence, | ||
| + | combating cancer. Advanced sequencing technology allows us to delve deeper T-cell receptor | ||
| + | (TCR) repertoire and gene expression. To better understand the adaptive immune system, we | ||
| + | have developed the Network Analysis of Immune Repertoire (NAIR) software, utilizing cutting- | ||
| + | edge statistical approaches and machine learning tools. NAIR constructed sequence networks, | ||
| + | and more importantly, | ||
| + | TCR clusters across multiple samples. This reveals potential disease-specific signatures, paving | ||
| + | the way for targeted therapies. NAIR accommodates both bulk and single-cell sequencing data, | ||
| + | unravelling insights at cell level. Expanding NAIR's capabilities, | ||
| + | gene expression data using a Graph deep learning model, offering unprecedented insights into T | ||
| + | cell functionality. Additionally, | ||
| + | peptides by integrating TCR sequence vectorization, | ||
| + | learning framework. Through network analysis, advanced statistics, and deep learning, NAIR | ||
| + | represents a powerful platform to unlock the complex interplay between adaptive immune | ||
| + | system, disease progression, | ||
| + | system dynamics.. \\ | ||
| + | |||
| + | |||
| + | |||
| + | Biography of the speaker: Dr. Li Zhang is a Professor of Biostatistics in the Department of Medicine, Division of Hematology and Oncology, with a joint appointment in the Department of | ||
| + | Epidemiology and Biostatistics at the University of California San Francisco (UCSF). | ||
| + | She obtained her Ph.D. in Statistics from the University of Florida, and before joining | ||
| + | UCSF, she was an Assistant Professor at the Cleveland Clinic. She has extensive | ||
| + | experience in applying statistics and developing advanced approaches in biomedical | ||
| + | research and expertise in cancer research with high-throughput sequencing data | ||
| + | analysis. She has published more than 150 papers and designed more than 60 Phase | ||
| + | I and II clinical trial studies. Dr. Zhang also serves on Global Action Plan 6 Project for | ||
| + | Movember Foundation as the UCSF site PI. She has been or is on multiple NIH, DOD, | ||
| + | and foundation grants as a co-Investigator. Her research interest focuses on | ||
| + | Immuno-informatics, | ||
| + | focusing on cancer Immunoinformatics. In addition to regularly teaching | ||
| + | Biostatistics and serving on students&# | ||
| + | UCSF&# | ||
| + | She also initiated and organizes the annual UCSF cancer center Biostatistics | ||
| + | workshop, which aims to provide education to scientists, post-docs, and technicians. | ||
| + | Dr. Zhang is very active member of professional community, she was the president | ||
| + | of the San Francisco Bay Area Chapter of American Statistical Association (SFASA), | ||
| + | now serves the Director of Education in SFASA. She is also a member of the | ||
| + | Pathways To Promotion Committee of ASA Statistical Consulting Section. She received | ||
| + | outstanding services award from ASA in 2021. | ||
| + | |||
| + | </ | ||
| + | |||
